Press Releases - Kerecis

Kerecis Completes Successful Immunology Study

Kerecis Communications May 3, 2013 No Comments

Symposium on Advanced Wound Care, Denver, Colorado, May 3, 2013— Kerecis today announced that its recent clinical trial found no allergenic reactions to its fish-skin-composed MariGen Omega3 technology. In the trial,…

Kerecis Completes US$ 1 Million Series A2 Funding

Kerecis Communications April 26, 2013 No Comments

Reykjavik / Isafjordur, Iceland, April 26, 2013 – Kerecis Limited, the emerging tissue-regeneration company, today announced that it has secured US$ 1 million in series A2 funding. The financing, a…

Kerecis Announces a Distribution Agreement with Medline Industries for the MariGen Omega3 Tissue-regeneration Technology

Kerecis Communications January 31, 2013 No Comments

Dubai, United Arab Emirates, January 31, 2013 — At the Arab Health Conference today, Kerecis announced the signing of a distribution agreement with Medline Industries, Inc. based in Mundelein, Illinois.…

Follow-Up Study Demonstrates Safety and Efficacy of Omega3 Wound-Healing Treatment

Kerecis Communications May 18, 2012 No Comments

Reykjavik/Isafjordur, Iceland, May 18, 2012 — Kerecis, the emerging tissue-regeneration company, has successfully completed a 37-patient follow-up study of its MariGen Wound treatment product for chronic wounds. MariGen Wound is…

Clinical Trial Demonstrates Safety and Efficacy of Wound-Healing Treatment

Kerecis Communications October 6, 2011 No Comments

Reykjavik/Isafjordur, Iceland, October 6, 2011 — Kerecis, the emerging tissue-regeneration company, has successfully completed the first human clinical trial of its MariGen Lipid Collagen Matrix. The MariGen matrix, which contains…

Minister of Industry Inaugurates Fish Skin Medical Device Facility

Kerecis Communications September 26, 2011 No Comments

Reykjavik/Isafjordur, Iceland, September 26, 2011 — Iceland’s Minister of Industry Katrin Juliusdottir today inaugurated the Kerecis Medical Device manufacturing facility in Isafjordur, Iceland. The only one of its kind in…

Kerecis to Present at IN3 East Investor Conference in Boston, June 21 – 23, 2011

Kerecis Communications June 20, 2011 No Comments

Reykjavik/Isafjordur, Iceland, June 20, 2011 — Kerecis Limited, the emerging tissue-regeneration company, today announced that its founder and CEO G. Fertram Sigurjonsson will make a presentation at Elsevier’s IN3 East…

Kerecis Completes Interim Financing

Kerecis Communications May 24, 2011 No Comments

Reykjavik/Isafjordur, Iceland, May 24, 2011 – Kerecis Limited, the emerging tissue-regeneration company, has secured US$ 1 million in interim financing. The US$ 1 million financing is a mixture of equity,…

Kerecis Limited Receives ISO 13485:2003 Quality Management System Certification

Kerecis Communications March 24, 2011 No Comments

Reykjavik/Isafjordur, Iceland, March 24, 2011 — Kerecis Limited, the emerging tissue-regeneration company, has received the International Organization for Standardization (ISO) 13485:2003 certificate for the “Design, development and production of wound…

Kerecis to Present at Investment Forums in London and New York

Kerecis Communications November 3, 2010 No Comments

Reykjavik/Isafjordur, Iceland, November 3, 2010 — Kerecis ehf, the emerging tissue-regeneration company, today announced that its Chairman G. Fertram Sigurjonsson will make presentations at investment forums this week and next.…

Kerecis Announces New Directors Eythor Bender and Egill Masson

Kerecis Communications October 8, 2010 No Comments

Reykjavik/Isafjordur, Iceland, October 8th, 2010 — Kerecis, the emerging tissue-regeneration company, today announced that Eythor Bender and Egill Masson were elected to the company’s Board of Directors at the Annual…

Research Collaboration Between Kerecis and ValaMed

Kerecis Communications July 14, 2010 No Comments

Two startup companies in the field of health medicine to collaborate Reykjavik/Isafjordur, Iceland, July 14, 2010 — Kerecis, the emerging tissue-regeneration company, and the chemo-sensitivity-testing company ValaMed have signed a…

Kerecis to Present at IN3 East Investor Conference in Boston, June 10 – 11, 2010

Kerecis Communications June 9, 2010 No Comments

REYKJAVIK, ICELAND and ISAFJORDUR, ICELAND–(Marketwire – June 9, 2010) – Kerecis ehf., the emerging tissue-regeneration company, today announced that its Chairman G. Fertram Sigurjonsson will make a presentation at Elsevier’s…

Kerecis Announces New VP of Science and Technology

Kerecis Communications May 3, 2010 No Comments

REYKJAVIK, ICELAND and ISAFJORDUR, ICELAND–(Marketwire – May 3, 2010) – Kerecis, the emerging tissue-regeneration company, has appointed Dr. Gudmundur Gudmundsson as vice president of science and technology. Dr. Gudmundsson has…

Kerecis Closes Start-Up Financing Round with the New Business Venture Fund

Kerecis Communications January 1, 2010 No Comments

REYKJAVIK, ICELAND and ISAFJORDUR, ICELAND–(Marketwire – January 4, 2010) – Kerecis, the emerging tissue-regeneration company, has successfully closed a seed financing round with the New Business Venture Fund. The Fund,…

Category: Press Releases